Assembly Biosciences CMO Buys 14,000 Shares on Zero‑Cash Deal, Boosting Insider Confidence Amid Stock Decline
Assembly Biosciences insider buys signal confidence amid a steep fall, but investors must weigh long‑term HBV‑cure potential against short‑term volatility.
3 minutes to read



